Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 Par Value (DNTH)

Historical Holders from Q3 2023 to Q1 2025

Symbol
DNTH on Nasdaq
CUSIP
252828108
Type / Class
Equity / Common Stock, $0.001 Par Value
Shares outstanding
32.1M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
35.1M
Holdings value
$766M
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
94
Number of buys
47
Number of sells
-35
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 Par Value (DNTH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avidity Partners Management LP 9.9% $61.3M 3.38M Avidity Partners Management LP Mar 17, 2025
RA CAPITAL MANAGEMENT, L.P. 9.4% $52M 2.87M RA Capital Management, L.P. Dec 31, 2024
BCLS Fund III Investments, LP 8.8% $48.8M 2.69M BCLS Fund III Investments, LP Dec 31, 2024
Deep Track Capital, LP 7.34% $42.8M 2.36M Deep Track Capital, LP Mar 17, 2025
Octagon Capital Advisors LP 7.1% $38.3M 2.11M Octagon Capital Advisors LP Dec 31, 2024
Point72 Asset Management, L.P. 5.9% $34.4M 1.89M Point72 Asset Management, L.P. Apr 10, 2025

Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 Par Value (DNTH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 42.6K $773K -$60.2K $18.14 5
2024 Q4 35.1M $766M +$63.2M $21.80 94
2024 Q3 31.4M $859M +$44.8M $27.38 90
2024 Q2 29.7M $769M +$87.6M $25.88 74
2024 Q1 26.1M $782M +$479M $30.00 75
2023 Q4 10.3M $107M +$520K $10.40 38
2023 Q3 10.1M $136M +$136M $13.67 30